| Item Type | Name |
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Urinary Bladder Diseases
|
|
Concept
|
Autoimmune Diseases
|
|
Concept
|
Brain Diseases
|
|
Concept
|
Communicable Diseases
|
|
Concept
|
Neurodegenerative Diseases
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Corneal Diseases
|
|
Concept
|
Alzheimer Disease
|
|
Concept
|
Occupational Diseases
|
|
Concept
|
Disease Progression
|
|
Concept
|
Kidney Diseases
|
|
Concept
|
Nose Diseases
|
|
Concept
|
Acute Disease
|
|
Concept
|
Lewy Body Disease
|
|
Concept
|
Diseases in Twins
|
|
Concept
|
Neuromuscular Diseases
|
|
Concept
|
Disease Outbreaks
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Disease Management
|
|
Concept
|
Nervous System Diseases
|
|
Concept
|
Parkinson Disease, Postencephalitic
|
|
Concept
|
Prion Diseases
|
|
Concept
|
Charcot-Marie-Tooth Disease
|
|
Concept
|
Autonomic Nervous System Diseases
|
|
Concept
|
Parkinson Disease
|
|
Concept
|
Basal Ganglia Diseases
|
|
Concept
|
Parkinson Disease, Secondary
|
|
Concept
|
Heart Diseases
|
|
Concept
|
Muscular Diseases
|
|
Concept
|
Huntington Disease
|
|
Concept
|
Peripheral Nervous System Diseases
|
|
Concept
|
Metabolic Diseases
|
|
Academic Article
|
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
|
|
Academic Article
|
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
|
|
Academic Article
|
The first miracle in neurodegenerative disease: the discovery of oral levodopa.
|
|
Academic Article
|
Missing pieces in the Parkinson's disease puzzle.
|
|
Academic Article
|
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
|
|
Academic Article
|
Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
|
|
Academic Article
|
Neuropharmacology in the elderly.
|
|
Academic Article
|
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease.
|
|
Academic Article
|
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
|
|
Academic Article
|
An update expert opinion on management and research strategies in Parkinson's disease psychosis.
|
|
Academic Article
|
Therapeutic approaches.
|
|
Academic Article
|
I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.
|
|
Academic Article
|
Hemiparkinsonism with hemiatrophy.
|
|
Academic Article
|
History of Parkinson's disease.
|
|
Academic Article
|
Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
|
|
Academic Article
|
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.
|
|
Academic Article
|
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
|
|
Academic Article
|
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.
|
|
Academic Article
|
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
|
|
Academic Article
|
Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease.
|
|
Academic Article
|
Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
|
|
Academic Article
|
Risk factors for progression in Parkinson's disease.
|
|
Academic Article
|
Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
|
|
Academic Article
|
Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing.
|
|
Academic Article
|
"On" freezing in Parkinson's disease: resistance to visual cue walking devices.
|
|
Academic Article
|
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
|
|
Academic Article
|
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
|
|
Academic Article
|
Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
|
|
Academic Article
|
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
|
|
Academic Article
|
Neuropathic features in fragile X premutation carriers.
|
|
Academic Article
|
Progressive cognitive decline with truncal/limb ataxia and ballistic movements.
|
|
Academic Article
|
Clinical presentation and pharmacological therapy in corticobasal degeneration.
|
|
Academic Article
|
Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
|
|
Academic Article
|
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
|
|
Academic Article
|
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor.
|
|
Academic Article
|
Movement disorders in Kuru.
|
|
Academic Article
|
Menstrual-related changes in motoric function in women with Parkinson's disease.
|
|
Academic Article
|
The malignant course of "benign hallucinations" in Parkinson disease.
|
|
Academic Article
|
Movement disorders caused by medical disease.
|
|
Academic Article
|
[Progressive supranuclear palsy].
|
|
Academic Article
|
Longitudinal outcome of Parkinson's disease patients with psychosis.
|
|
Academic Article
|
Coping strategies for visual hallucinations in Parkinson's disease.
|
|
Academic Article
|
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
|
|
Academic Article
|
Pierre Marie: gifted intellect, poor timing and unchecked emotionality.
|
|
Academic Article
|
Wheeled and standard walkers in Parkinson's disease patients with gait freezing.
|
|
Academic Article
|
Impact of placebo assignment in clinical trials of Parkinson's disease.
|
|
Academic Article
|
Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome.
|
|
Academic Article
|
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
|
|
Academic Article
|
Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program.
|
|
Academic Article
|
Re: UPDRS: Status and recommendations.
|
|
Academic Article
|
Apolipoprotein E controls the risk and age at onset of Parkinson disease.
|
|
Academic Article
|
The origins of scientific cinematography and early medical applications.
|
|
Academic Article
|
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
|
|
Academic Article
|
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
|
|
Academic Article
|
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape.
|
|
Academic Article
|
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model.
|
|
Academic Article
|
Altered cortical visual processing in PD with hallucinations: an fMRI study.
|
|
Academic Article
|
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.
|
|
Academic Article
|
Movement disorders: understanding clinical trials.
|
|
Academic Article
|
Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.
|
|
Academic Article
|
A responsive outcome for Parkinson's disease neuroprotection futility studies.
|
|
Academic Article
|
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
|
|
Academic Article
|
[Supratentorial primitive neuroectodermal tumor: a single center experience and comparison with the literature].
|
|
Academic Article
|
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
|
|
Academic Article
|
Movement disorders associated with encephalitis lethargica: a video compilation.
|
|
Academic Article
|
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
|
|
Academic Article
|
Hallucinations in Parkinson disease in the prelevodopa era.
|
|
Academic Article
|
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials.
|
|
Academic Article
|
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
|
|
Academic Article
|
Does seasonal variation affect hallucinations in PD? A longitudinal study.
|
|
Academic Article
|
Safety of rasagiline in elderly patients with Parkinson disease.
|
|
Academic Article
|
Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
|
|
Academic Article
|
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
|
|
Academic Article
|
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
|
|
Academic Article
|
What's new? Clinical progression and staging of Parkinson's disease.
|
|
Academic Article
|
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
|
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
|
|
Academic Article
|
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
|
|
Academic Article
|
Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
|
|
Academic Article
|
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
|
|
Academic Article
|
Depression rating scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.
|
|
Academic Article
|
Levodopa-induced dyskinesias.
|
|
Academic Article
|
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
|
|
Academic Article
|
J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies.
|
|
Academic Article
|
Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies.
|
|
Academic Article
|
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
|
|
Academic Article
|
Placebo influences on dyskinesia in Parkinson's disease.
|
|
Academic Article
|
Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
|
|
Academic Article
|
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
|
|
Academic Article
|
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
|
|
Academic Article
|
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
|
|
Academic Article
|
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.
|
|
Academic Article
|
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
|
|
Academic Article
|
Anxiety rating scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
|
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
|
|
Academic Article
|
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.
|
|
Academic Article
|
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
|
|
Academic Article
|
Hallucinations in Parkinson disease.
|
|
Academic Article
|
Using global statistical tests in long-term Parkinson's disease clinical trials.
|
|
Academic Article
|
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
|
|
Academic Article
|
Jean-Martin Charcot and his vibratory chair for Parkinson disease.
|
|
Academic Article
|
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
|
|
Academic Article
|
[Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease].
|
|
Academic Article
|
Scales to evaluate psychosis in Parkinson's disease.
|
|
Academic Article
|
New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease.
|
|
Academic Article
|
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.
|
|
Academic Article
|
Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor.
|
|
Academic Article
|
Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
|
|
Academic Article
|
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
|
|
Academic Article
|
A 12-year population-based study of psychosis in Parkinson disease.
|
|
Academic Article
|
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study.
|
|
Academic Article
|
Priorities in Parkinson's disease research.
|
|
Academic Article
|
The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.
|
|
Academic Article
|
Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.
|
|
Academic Article
|
Wearing-off scales in Parkinson's disease: critique and recommendations.
|
|
Academic Article
|
Temporal stability of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
|
|
Academic Article
|
Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.
|
|
Academic Article
|
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
|
|
Academic Article
|
The history of Parkinson's disease: early clinical descriptions and neurological therapies.
|
|
Academic Article
|
Tai chi for patients with Parkinson's disease.
|
|
Academic Article
|
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.
|
|
Academic Article
|
Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
|
|
Academic Article
|
Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.
|
|
Academic Article
|
Which dyskinesia scale best detects treatment response?
|
|
Academic Article
|
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
|
|
Academic Article
|
The Parkinson's disease multidisciplinary package.
|
|
Academic Article
|
Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
|
|
Academic Article
|
Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.
|
|
Academic Article
|
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
|
|
Academic Article
|
Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.
|
|
Academic Article
|
Vibration therapy for Parkinson's disease: Charcot's studies revisited.
|
|
Academic Article
|
Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
|
|
Academic Article
|
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
|
|
Academic Article
|
Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
|
|
Academic Article
|
A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.
|
|
Academic Article
|
Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example.
|
|
Academic Article
|
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.
|
|
Academic Article
|
Are patients with Parkinson's disease blind to blindsight?
|
|
Academic Article
|
The past, present, and future of telemedicine for Parkinson's disease.
|
|
Academic Article
|
Initial management of Parkinson's disease.
|
|
Academic Article
|
Handling missing values in the MDS-UPDRS.
|
|
Academic Article
|
Preface.
|
|
Academic Article
|
MDS clinical diagnostic criteria for Parkinson's disease.
|
|
Academic Article
|
MDS research criteria for prodromal Parkinson's disease.
|
|
Academic Article
|
Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.
|
|
Academic Article
|
Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations.
|
|
Academic Article
|
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
|
|
Academic Article
|
The new definition and diagnostic criteria of Parkinson's disease.
|
|
Academic Article
|
Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
|
|
Academic Article
|
Chronic agonist-induced hypersensitivity and on-off hyperkinesis.
|
|
Academic Article
|
Lergotrile in the treatment of parkinsonism.
|
|
Academic Article
|
Levodopa-induced dopamine receptor hypersensitivity.
|
|
Academic Article
|
Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.
|
|
Academic Article
|
Levodopa-induced myoclonus.
|
|
Academic Article
|
Dopaminergic agonists in the treatment of Parkinson's disease.
|
|
Academic Article
|
Ideational fluency in Parkinson's disease.
|
|
Academic Article
|
Core assessment program for intracerebral transplantations (CAPIT).
|
|
Academic Article
|
Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease.
|
|
Academic Article
|
Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.
|
|
Academic Article
|
Gilles de la Tourette's syndrome in twins: clinical and neurochemical data.
|
|
Academic Article
|
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
|
|
Academic Article
|
United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.
|
|
Academic Article
|
Dopaminergic agonists in the treatment of Parkinson's disease.
|
|
Academic Article
|
Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.
|
|
Academic Article
|
Effects of head trauma from motor vehicle accidents on Parkinson's disease.
|
|
Academic Article
|
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease.
|
|
Academic Article
|
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
|
|
Academic Article
|
New approaches in the treatment of the dystonias.
|
|
Academic Article
|
Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results.
|
|
Academic Article
|
United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up.
|
|
Academic Article
|
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor.
|
|
Academic Article
|
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data.
|
|
Academic Article
|
Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes.
|
|
Academic Article
|
Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease.
|
|
Academic Article
|
Hypersexuality with antiparkinsonian therapy.
|
|
Academic Article
|
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
|
|
Academic Article
|
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.
|
|
Academic Article
|
Environmental factors and Parkinson's disease: a case-control study in China.
|
|
Academic Article
|
Agonist substitution in advanced Parkinson's disease.
|
|
Academic Article
|
The pathophysiology of tardive dyskinesia.
|
|
Academic Article
|
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
|
|
Academic Article
|
Case 2, 1988. Congenital mental retardation and juvenile parkinsonism.
|
|
Academic Article
|
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.
|
|
Academic Article
|
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.
|
|
Academic Article
|
Charcot on Parkinson's disease.
|
|
Academic Article
|
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients.
|
|
Academic Article
|
Amantadine and motor fluctuations in chronic Parkinson's disease.
|
|
Academic Article
|
Drug-induced myoclonus.
|
|
Academic Article
|
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
|
|
Academic Article
|
Pain in Parkinson's disease.
|
|
Academic Article
|
Progression of Parkinson's disease without levodopa.
|
|
Academic Article
|
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
|
|
Academic Article
|
Controlled-release Sinemet.
|
|
Academic Article
|
Relationships among pain, depression, and sleep alterations in Parkinson's disease.
|
|
Academic Article
|
Pergolide mesylate: four years experience in Parkinson's disease.
|
|
Academic Article
|
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease.
|
|
Academic Article
|
Autonomic dysfunction in Parkinson's disease.
|
|
Academic Article
|
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
|
|
Academic Article
|
Tardive dyskinesia: review and update.
|
|
Academic Article
|
Drug-induced extrapyramidal disorders - a neuropsychiatric interface.
|
|
Academic Article
|
Drug-induced Parkinsonism and idiopathic Parkinson's disease.
|
|
Academic Article
|
Animal models of tardive dyskinesias.
|
|
Academic Article
|
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
|
|
Academic Article
|
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
|
|
Academic Article
|
Bupropion in Parkinson's disease.
|
|
Academic Article
|
Presymptomatic and early detection in Huntington's disease.
|
|
Academic Article
|
The pharmacology of olivopontocerebellar atrophy.
|
|
Academic Article
|
Pergolide in Parkinson's disease.
|
|
Academic Article
|
Drug holiday in the management of Parkinson disease.
|
|
Academic Article
|
Pharmacology of hallucinations induced by long-term drug therapy.
|
|
Academic Article
|
Levodopa-free periods ("drug holidays") in the management of parkinsonism.
|
|
Academic Article
|
Pergolide mesylate and idiopathic Parkinson disease.
|
|
Academic Article
|
The effect of bromocriptine (BCT) on the on-off phenomenon.
|
|
Academic Article
|
Weekly drug holiday in Parkinson disease.
|
|
Academic Article
|
A pure parkinsonian syndrome following acute carbon monoxide intoxication.
|
|
Academic Article
|
Complications of chronic levodopa therapy: long-term efficacy of drug holiday.
|
|
Academic Article
|
Practical guidelines for drug holidays in parkinsonian patients.
|
|
Academic Article
|
Drug-induced asterixis in Parkinson disease.
|
|
Academic Article
|
CPK values in Parkinson's disease.
|
|
Academic Article
|
Teaching tape for the motor section of the unified Parkinson's disease rating scale.
|
|
Academic Article
|
Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.
|
|
Academic Article
|
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
|
|
Academic Article
|
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.
|
|
Academic Article
|
Akathisia in Parkinson's disease.
|
|
Academic Article
|
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.
|
|
Academic Article
|
The role of surgery in Parkinson's disease management.
|
|
Academic Article
|
Physical therapy and Parkinson's disease: a controlled clinical trial.
|
|
Academic Article
|
Neurologic health outcomes and Agent Orange: Institute of Medicine report.
|
|
Academic Article
|
Renal complications of infected ventriculoatrial shunts.
|
|
Academic Article
|
[Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results].
|
|
Academic Article
|
Risk factors for nursing home placement in advanced Parkinson's disease.
|
|
Academic Article
|
Fetal-tissue transplantation for Parkinson's disease.
|
|
Academic Article
|
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
|
|
Academic Article
|
Neurosurgical horizons in Parkinson's disease.
|
|
Academic Article
|
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise.
|
|
Academic Article
|
Prevalence of parkinsonian signs and associated mortality in a community population of older people.
|
|
Academic Article
|
There is a renaissance of interest in pallidotomy for Parkinson's disease.
|
|
Academic Article
|
Pramipexole in patients with early Parkinson's disease.
|
|
Academic Article
|
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
|
|
Academic Article
|
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use.
|
|
Academic Article
|
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
|
|
Academic Article
|
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.
|
|
Academic Article
|
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels.
|
|
Academic Article
|
An early photographic case of probable progressive supranuclear palsy.
|
|
Academic Article
|
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.
|
|
Academic Article
|
[Botulin toxin: principles of action and neurological indications].
|
|
Academic Article
|
Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning.
|
|
Academic Article
|
New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists.
|
|
Academic Article
|
Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
|
|
Academic Article
|
Treatment with fetal allografts.
|
|
Academic Article
|
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
|
|
Academic Article
|
The stability of carbidopa in solution.
|
|
Academic Article
|
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
|
|
Academic Article
|
Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
|
|
Academic Article
|
Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease.
|
|
Academic Article
|
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations.
|
|
Academic Article
|
Highlights of the North American and European experiences.
|
|
Academic Article
|
Influence of COMT inhibition on levodopa pharmacology and therapy.
|
|
Academic Article
|
New lessons from old drugs: amantadine and Parkinson's disease.
|
|
Academic Article
|
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.
|
|
Academic Article
|
Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
|
|
Academic Article
|
Early dopaminergic drug-induced hallucinations in parkinsonian patients.
|
|
Academic Article
|
Poor visual discrimination and visual hallucinations in Parkinson's disease.
|
|
Academic Article
|
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease.
|
|
Academic Article
|
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists.
|
|
Academic Article
|
Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?
|
|
Academic Article
|
Delayed recognition memory in Parkinson's disease: a role for working memory?
|
|
Academic Article
|
Hallucinations in Parkinson's disease: the clinical syndrome.
|
|
Academic Article
|
Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state.
|
|
Academic Article
|
Parkinson's disease.
|
|
Academic Article
|
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.
|
|
Academic Article
|
Rating scales for dyskinesias in Parkinson's disease.
|
|
Academic Article
|
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.
|
|
Academic Article
|
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease.
|
|
Academic Article
|
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
|
|
Academic Article
|
Decreased color discrimination and contrast sensitivity in Parkinson's disease.
|
|
Academic Article
|
Objective changes in motor function during placebo treatment in PD.
|
|
Academic Article
|
Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease.
|
|
Academic Article
|
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease.
|
|
Academic Article
|
[Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison].
|
|
Academic Article
|
Differential progression of motor impairment in levodopa-treated Parkinson's disease.
|
|
Academic Article
|
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys.
|
|
Academic Article
|
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
|
|
Academic Article
|
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
|
|
Academic Article
|
Visual hallucinations induced by deep brain stimulation in Parkinson's disease.
|
|
Academic Article
|
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
|
|
Academic Article
|
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
|
|
Academic Article
|
Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
|
|
Academic Article
|
Complete genomic screen in Parkinson disease: evidence for multiple genes.
|
|
Academic Article
|
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
|
|
Academic Article
|
Prospective longitudinal assessment of hallucinations in Parkinson's disease.
|
|
Academic Article
|
Age at onset in two common neurodegenerative diseases is genetically controlled.
|
|
Academic Article
|
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
|
|
Academic Article
|
Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
|
|
Academic Article
|
History of the extensor plantar response: Babinski and Chaddock signs.
|
|
Academic Article
|
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.
|
|
Academic Article
|
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
|
|
Academic Article
|
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
|
|
Academic Article
|
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
|
|
Academic Article
|
Part 1: the history of 19th century neurology and the American Neurological Association.
|
|
Academic Article
|
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.
|
|
Academic Article
|
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
|
|
Academic Article
|
Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version.
|
|
Academic Article
|
Disability Rating Scales in Parkinson's Disease: Critique and Recommendations.
|
|
Academic Article
|
Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.
|
|
Academic Article
|
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.
|
|
Academic Article
|
Abolishing the 1-year rule: How much evidence will be enough?
|
|
Academic Article
|
Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.
|
|
Academic Article
|
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
|
|
Academic Article
|
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
|
|
Academic Article
|
Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale.
|
|
Academic Article
|
Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations".
|
|
Academic Article
|
Untitled Publication
|
|
Academic Article
|
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
|
|
Academic Article
|
[Where are the grafts in Parkinson's disease?].
|
|
Academic Article
|
Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.
|
|
Academic Article
|
Rating scales for cognition in Huntington's disease: Critique and recommendations.
|
|
Academic Article
|
Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study.
|
|
Academic Article
|
Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.
|
|
Academic Article
|
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.
|
|
Academic Article
|
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.
|
|
Academic Article
|
[Practical assessment of DSAEK in the management of endothelial decompensation following penetrating keratoplasty].
|
|
Academic Article
|
What influences placebo and nocebo responses in Parkinson's disease?
|
|
Academic Article
|
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
|
|
Academic Article
|
Movement disorder society criteria for clinically established early Parkinson's disease.
|
|
Academic Article
|
Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.
|
|
Academic Article
|
Sildenafil in the Treatment of Erectile Dysfunction in Parkinson's Disease.
|
|
Academic Article
|
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration.
|
|
Academic Article
|
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.
|
|
Academic Article
|
The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's Disease.
|
|
Academic Article
|
Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations.
|
|
Academic Article
|
Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.
|
|
Academic Article
|
Parkinson's disease: Is it a consequence of human brain evolution?
|
|
Academic Article
|
The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.
|
|
Academic Article
|
Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.
|
|
Academic Article
|
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
|
|
Academic Article
|
Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-duration.
|
|
Academic Article
|
The Progressive Supranuclear Palsy Clinical Deficits Scale.
|
|
Academic Article
|
Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease.
|
|
Academic Article
|
Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era.
|
|
Academic Article
|
Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items.
|
|
Academic Article
|
The Evolution-Driven Signature of Parkinson's Disease.
|
|
Academic Article
|
Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Preface.
|
|
Academic Article
|
Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
|
|
Academic Article
|
Optimizing DyNaChron instrument for assessing chronic nasal dysfunction symptoms by Rasch analysis.
|
|
Academic Article
|
Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales.
|
|
Academic Article
|
Apathy in Parkinson disease: Why we should care.
|
|
Academic Article
|
COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?
|
|
Academic Article
|
Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS).
|
|
Academic Article
|
A novel quantitative metric for joint space width: data from the Osteoarthritis Initiative (OAI).
|
|
Academic Article
|
Attenuated Postprandial GLP-1 Response in Parkinson's Disease.
|
|
Academic Article
|
Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change.
|
|
Academic Article
|
Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocol.
|
|
Academic Article
|
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
|
|
Academic Article
|
Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models.
|
|
Academic Article
|
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
|
|
Academic Article
|
Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1.
|
|
Academic Article
|
Parkinson's Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan.
|
|
Academic Article
|
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
|
|
Academic Article
|
Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease.
|
|
Academic Article
|
Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine.
|
|
Academic Article
|
Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico Study.
|
|
Academic Article
|
Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
|
|
Academic Article
|
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
|
|
Academic Article
|
Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.
|
|
Academic Article
|
Cross-Cultural Differences in Patient Perceptions of Dyskinesia in Parkinson's Disease.
|
|
Academic Article
|
The plight of loneliness in Parkinson's disease: New opportunities.
|
|
Academic Article
|
Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States.
|
|
Academic Article
|
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.
|
|
Academic Article
|
Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations.
|
|
Academic Article
|
Are Virtual Objective Assessments of Fall-Risk Feasible and Safe for People with Parkinson's Disease?
|
|
Academic Article
|
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease.
|